UY32486A - Tratamiento del cáncer de páncreas - Google Patents
Tratamiento del cáncer de páncreasInfo
- Publication number
- UY32486A UY32486A UY0001032486A UY32486A UY32486A UY 32486 A UY32486 A UY 32486A UY 0001032486 A UY0001032486 A UY 0001032486A UY 32486 A UY32486 A UY 32486A UY 32486 A UY32486 A UY 32486A
- Authority
- UY
- Uruguay
- Prior art keywords
- cancer
- treatment
- iodophenylamino
- fluoro
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se relaciona con el campo de la oncología y con el uso de la (S) -N-(3,4-difluoro-2-(2- fluoro-4-iodofenilaminoi)-6-metoxifenil)-1-(2,3-dihidroxi-propil)ciclopropano-1-sulfonamida o de una sal farmacéuticamente aceptable de ésta, o de la N-(4-(2-fluoro-4-iodofenilamino)-1,5-dimetil-6-oxo-1,6-dihidropiridin-3-il)ciclopropanosulfonamida o de una forma polimórfica de ésta o de una sal farmacéuticamente aceptable de ésta, o de composiciones farmacéuticas que las comprenden, para la preparación de un medicamento para el tatamiento del cáncer de páncreas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15939709P | 2009-03-11 | 2009-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY32486A true UY32486A (es) | 2010-10-29 |
Family
ID=42129806
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001032486A UY32486A (es) | 2009-03-11 | 2010-03-10 | Tratamiento del cáncer de páncreas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20120053211A1 (es) |
| EP (1) | EP2405907A1 (es) |
| JP (1) | JP2012520319A (es) |
| KR (1) | KR20110128916A (es) |
| CN (1) | CN102438609A (es) |
| AU (1) | AU2010224108A1 (es) |
| BR (1) | BRPI1009435A2 (es) |
| CA (1) | CA2754891A1 (es) |
| CL (1) | CL2011002234A1 (es) |
| CR (1) | CR20110478A (es) |
| EA (1) | EA201101305A1 (es) |
| IL (1) | IL215037A0 (es) |
| MA (1) | MA33109B1 (es) |
| MX (1) | MX2011009494A (es) |
| SG (1) | SG174271A1 (es) |
| SV (1) | SV2011004017A (es) |
| TN (1) | TN2011000456A1 (es) |
| TW (1) | TW201100081A (es) |
| UY (1) | UY32486A (es) |
| WO (1) | WO2010105082A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20121471A1 (es) | 2009-11-04 | 2012-11-01 | Novartis Ag | Derivados de sulfonamida heterociclicos utiles como inhibidores de mek |
| EP2916859B1 (en) | 2012-11-02 | 2017-06-28 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Method of reducing adverse effects in a cancer patient undergoing treatment with a mek inhibitor |
| CN103267852B (zh) * | 2013-05-15 | 2015-03-25 | 中国医学科学院北京协和医院 | 成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途 |
| PL3484486T3 (pl) * | 2016-07-15 | 2023-12-11 | H2 Water Technologies Ltd | Kompozycja do produkcji wody bogatej w wodór |
| KR101980809B1 (ko) * | 2017-09-29 | 2019-05-21 | 대한민국 | 귀리껍질 추출물을 포함하는 췌장암의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9022A (en) * | 1852-06-15 | Organ | ||
| US8005A (en) * | 1851-04-01 | He ne y bo o t | ||
| WO2009018233A1 (en) * | 2007-07-30 | 2009-02-05 | Ardea Biosciences, Inc. | Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| US8101799B2 (en) * | 2005-07-21 | 2012-01-24 | Ardea Biosciences | Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK |
| EA016674B1 (ru) * | 2006-04-18 | 2012-06-29 | Ардеа Байосайенсиз, Инк. | Пиридон сульфонамиды и пиридон сульфамиды в качестве ингибиторов mek |
| US8044240B2 (en) * | 2008-03-06 | 2011-10-25 | Ardea Biosciences Inc. | Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof |
-
2010
- 2010-03-10 UY UY0001032486A patent/UY32486A/es not_active Application Discontinuation
- 2010-03-11 KR KR1020117023719A patent/KR20110128916A/ko not_active Application Discontinuation
- 2010-03-11 JP JP2011554208A patent/JP2012520319A/ja active Pending
- 2010-03-11 AU AU2010224108A patent/AU2010224108A1/en not_active Abandoned
- 2010-03-11 SG SG2011064284A patent/SG174271A1/en unknown
- 2010-03-11 US US13/255,331 patent/US20120053211A1/en not_active Abandoned
- 2010-03-11 WO PCT/US2010/027021 patent/WO2010105082A1/en active Application Filing
- 2010-03-11 BR BRPI1009435A patent/BRPI1009435A2/pt not_active IP Right Cessation
- 2010-03-11 EA EA201101305A patent/EA201101305A1/ru unknown
- 2010-03-11 MX MX2011009494A patent/MX2011009494A/es not_active Application Discontinuation
- 2010-03-11 MA MA34154A patent/MA33109B1/fr unknown
- 2010-03-11 EP EP10708872A patent/EP2405907A1/en not_active Withdrawn
- 2010-03-11 CN CN2010800210090A patent/CN102438609A/zh active Pending
- 2010-03-11 TW TW099107104A patent/TW201100081A/zh unknown
- 2010-03-11 CA CA2754891A patent/CA2754891A1/en not_active Abandoned
-
2011
- 2011-09-08 IL IL215037A patent/IL215037A0/en unknown
- 2011-09-09 TN TN2011000456A patent/TN2011000456A1/fr unknown
- 2011-09-09 CR CR20110478A patent/CR20110478A/es not_active Application Discontinuation
- 2011-09-09 CL CL2011002234A patent/CL2011002234A1/es unknown
- 2011-09-09 SV SV2011004017A patent/SV2011004017A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TN2011000456A1 (en) | 2013-03-27 |
| SG174271A1 (en) | 2011-10-28 |
| EP2405907A1 (en) | 2012-01-18 |
| AU2010224108A1 (en) | 2011-09-22 |
| BRPI1009435A2 (pt) | 2016-03-01 |
| IL215037A0 (en) | 2011-11-30 |
| CN102438609A (zh) | 2012-05-02 |
| US20120053211A1 (en) | 2012-03-01 |
| EA201101305A1 (ru) | 2012-04-30 |
| CR20110478A (es) | 2011-10-24 |
| CL2011002234A1 (es) | 2012-01-27 |
| KR20110128916A (ko) | 2011-11-30 |
| MA33109B1 (fr) | 2012-03-01 |
| CA2754891A1 (en) | 2010-09-16 |
| TW201100081A (en) | 2011-01-01 |
| MX2011009494A (es) | 2011-10-11 |
| WO2010105082A1 (en) | 2010-09-16 |
| SV2011004017A (es) | 2012-01-06 |
| JP2012520319A (ja) | 2012-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1123810T1 (el) | Τριφθορομεθυλ υποκατεστημενα πυραζολια ως αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα | |
| CY1121729T1 (el) | Παραγωγα αρυλμεθοξυ ισοϊνδολινης και συνθεσεις που περιλαμβανουν αυτα και μεθοδοι χρησης αυτων | |
| CY1124432T1 (el) | Φαρμακευτικες συνθεσεις που αποτελουν ν-(3,5-διμεθοδυφαινυλ)-ν'-(1-μεθυλαιθυλ)-ν-[3-(1--μεθυλ-1η-πυραζολ-4-υλ)κινοοξαλιν-6-υλ]αιθανο-1,2-διαμινη | |
| CY1124652T1 (el) | Παραγωγα 1η-ινδαζολο-3-καρβοξαμιδιου και σχετικες ενωσεις ως αναστολεις παραγοντα d για τη θεραπεια νοσων που χαρακτηριζονται απο μη φυσιολογικη δραστηριοτητα συστηματος συμπληρωματος, οπως π.χ. ανοσολογικες διαταραχες | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| CY1119645T1 (el) | Τριπεπτιδικοι αναστολεις πρωτεασης εποξειδικης κετονης | |
| CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
| UY37842A (es) | Inhibidores de mcl-1 macrocíclicos y métodos de uso | |
| TR201901312T4 (tr) | Mcl-1 proteinini inhibe eden tetrahidronaftalen türevleri. | |
| UY37843A (es) | Inhibidores de mcl-1 macrocíclicos y métodos de uso | |
| CY1118662T1 (el) | Νεες δικυκλικες πυριδινονες | |
| BR112013028665A2 (pt) | compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos | |
| CL2008001868A1 (es) | Compuestos derivados de n-(2-(hetaril)aril)arilsulfonamidas y n-(2-(hetaril)hetaril)arilsulfonamidas; composicion farmaceutica que comprende a dicho compuesto; y uso para el tratamiento de enfermedades inflamatorias del intestino, enfermedad alergica | |
| CR20140086A (es) | Tratamientos de combinación para hepatitis c | |
| CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
| UY37844A (es) | Inhibidores de mcl-1 macrocíclicos y métodos de uso | |
| BR112014017780A8 (pt) | Compostos de sulfona tricíclicos e métodos para fazer e usar os mesmos | |
| CY1124907T1 (el) | Αναστολεις καλλικρεϊνης στο ανθρωπινο πλασμα | |
| UY37837A (es) | Nuevos compuestos heterocíclicos como inhibidores de cdk8/19 | |
| UY36123A (es) | Derivados de carboxamida | |
| ECSP19019613A (es) | Compuestos de azaindazol para usar en lesiones de tendones y/o ligamentos | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| AR086800A1 (es) | Composicion farmaceutica oftalmologica topica que contiene regorafenib | |
| UY32486A (es) | Tratamiento del cáncer de páncreas | |
| CU24434B1 (es) | Compuestos derivados de n-(1,5-dimetil-3-oxo-2,3-dihidro-1h-pirazol-4-il)-4-metil-5-isoxazol-3-carboxamida activos como inhibidores selectivos de smurf-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20190122 |